about
Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1So depression is an inflammatory disease, but where does the inflammation come from?Minocycline: therapeutic potential in psychiatryDopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorderAntioxidant treatments for schizophreniaAdjunctive antioxidants for bipolar disorderAntioxidant treatments for schizophreniaClotiapine for acute psychotic illnessesN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionThe role of lamotrigine in the management of bipolar disorderA review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisCognitive remission: a novel objective for the treatment of major depression?Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.Relationship between diet and mental health in children and adolescents: a systematic reviewEmerging pharmacotherapy for cancer patients with cognitive dysfunctionNucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effectsQuetiapine monotherapy in bipolar II depression: combined data from four large, randomized studiesOvarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancerGlutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsImprovement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapineOxidative stress in psychiatric disorders: evidence base and therapeutic implicationsThe Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune DiseaseN-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trialEfficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trialsPutative neuroprotective agents in neuropsychiatric disordersThe promise of N-acetylcysteine in neuropsychiatryQualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaOxidative pathways as a drug target for the treatment of autismLifestyle medicine for depressionLoss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- miceOnline information seeking by patients with bipolar disorder: results from an international multisite surveyThe association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in menOnline ethics: where will the interface of mental health and the internet lead us?Seasonal influences on first-episode admission in affective and non-affective psychosis.Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.Harnessing the potential of community-based participatory research approaches in bipolar disorderMental health system development in Asia: Does Australia have a role?Assessing regional cerebral blood flow in depression using 320-slice computed tomographyHow cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.
P50
Q21143774-873BDD1F-41A4-4DAA-8415-7A3892726B52Q21245291-87B960E0-E864-41B9-9445-C9A64F870BEBQ22241418-2DC359AC-8E6D-4538-B5E0-5A2FC2C4F2A8Q22242334-F39BA27C-3672-46F3-A98B-D72B1FB6172CQ24186162-FCA19EAA-5856-4FF4-9D98-04D1975CE012Q24198987-D6527BA6-0BE4-41B3-A01A-D387DE23A7BAQ24235143-F9C07AD5-C338-4299-93FF-C19FD0647314Q24246109-2329059F-40AE-40FF-B14A-96A37135DDFBQ24615952-88FA5EEB-56F1-473A-84AC-54F854C1D22AQ24658110-96600076-B542-46B8-A47D-F8119AFAB68AQ26748778-9850EC4F-27CF-4E4D-B1C4-2E7167693798Q26775386-74997BC1-1B16-45DC-AE78-7393928ACD33Q26823313-F4351E88-D97E-45D0-99B7-0139304B58B3Q26991758-5AC7E75F-402D-48A0-9FE1-A20FA2FAE3FCQ27026729-B3E5F127-5C7D-466A-89C9-DF155BF784C1Q27336543-5D0A2F14-84F4-4306-8AA5-0C434A837D88Q27499305-60B0A3AC-56FF-4BD3-820D-30A45F5671D9Q28242670-E076B1A0-9D00-4106-B071-97F270EC6EC7Q28257370-3590F286-E400-4CE7-87A5-50332FB99AE5Q28264482-211DCC26-6927-4529-8BBB-61FAB258E721Q28265319-03692318-76F5-4C55-A03D-F8B3D7D9F161Q28276657-5019B763-2AAD-416C-8256-0A7E565FE42FQ28277707-D53698DA-0935-4FE7-8CC8-563C8A9BA228Q28279325-1403953C-3E99-4C06-8587-48DBA1D1727DQ28279830-400A28CC-807A-4BE5-975F-15754593B745Q28284644-A0658C48-66EB-4E79-BB91-0F7FEE1E2AAFQ28294101-AC2D3B88-E972-4829-9911-466D2F7D0C4BQ28295948-078FB692-0399-4861-BC6F-A1B24AEE6B9AQ28384592-72BFB71D-5A8D-4ABB-A923-B023A178F565Q28510846-9AD08C5A-EA68-40D3-83A8-406C80295B69Q28597389-16A9D2D1-FF2A-4B3D-9D67-3DCC712C7C6CQ29247902-D84020F4-6C89-43D9-B787-7FFBF497A0AEQ29994517-C40846FB-46FB-48AE-92D1-33CB9E51C21FQ30230589-73EFA564-3429-4CD2-9F99-3359F05B2948Q30234571-7F5CBE5C-78F7-4D1B-BCBF-AAD69552E9D1Q30316281-F21B8E7C-914C-407A-99E6-07A937446A0BQ30384240-4DAF1748-A600-42E0-91A7-AFA574C3679EQ30387919-84D291E3-4B22-4822-B6F9-A26C65E02DC6Q30429330-44D3FB2E-CC85-4DD1-8713-587F619A772FQ30453328-53E59AA0-5C0F-4024-A18E-FE940D588A92
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michael Berk
@ast
Michael Berk
@en
Michael Berk
@es
Michael Berk
@fr
Michael Berk
@nl
Michael Berk
@sl
type
label
Michael Berk
@ast
Michael Berk
@en
Michael Berk
@es
Michael Berk
@fr
Michael Berk
@nl
Michael Berk
@sl
prefLabel
Michael Berk
@ast
Michael Berk
@en
Michael Berk
@es
Michael Berk
@fr
Michael Berk
@nl
Michael Berk
@sl
P214
P244
P1053
M-7891-2013
P106
P1153
55331293900
7102183860
P21
P214
P244
nb2015012749
P31
P3829
P496
0000-0002-5554-6946
P735
P7859
lccn-nb2015012749